Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Pharmacol Exp Ther ; 369(1): 37-46, 2019 04.
Article in English | MEDLINE | ID: mdl-30635471

ABSTRACT

Sustained ligand-activated preconditioning (SLP), induced with chronic opioid receptor (OR) agonism, enhances tolerance to ischemia/reperfusion injury in young and aged hearts. Underlying mechanisms remain ill-defined, although early data implicate phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) during the induction phase, and ß 2-adrenoceptor (ß 2-AR), Gs alpha subunit (Gα s), and protein kinase A (PKA) involvement in subsequent cardioprotection. Here, we tested for induction of a protective ß 2-AR/Gα s/PKA signaling axis with SLP to ascertain whether signaling changes were PI3K-dependent (by sustained cotreatment with wortmannin), and whether the downstream PKA target Rho kinase (ROCK) participates in subsequent cardioprotection (by acute treatment with fasudil). A protected phenotype was evident after 5 days of OR agonism (using morphine) in association with increased membrane versus reduced cytosolic levels of total and phosphorylated ß 2-ARs; increased membrane and cytosolic expression of 52 and 46 kDa Gα s isoforms, respectively; and increased phosphorylation of PKA and Akt. Nonetheless, functional sensitivities of ß 2-ARs and adenylyl cyclase were unchanged based on concentration-response analyses for formoterol, fenoterol, and 6-[3-(dimethylamino)propionyl]-forskolin. Protection with SLP was not modified by ROCK inhibition, and changes in ß 2-AR, Gα s, and PKA expression appeared insensitive to PI3K inhibition, although 5 days of wortmannin alone exerted unexpected effects on signaling (also increasing membrane ß 2-AR and PKA expression/phosphorylation and Gα s levels). In summary, sustained OR agonism upregulates cardiac membrane ß 2-AR expression and phosphorylation in association with increased Gα s subtype levels and PKA phosphorylation. While Akt phosphorylation was evident, PI3K activity appears nonessential to OR upregulation of the ß 2-AR signal axis. This opioidergic remodeling of ß 2-AR signaling may explain ß 2-AR, Gα s, and PKA dependence of SLP protection.


Subject(s)
Ischemic Preconditioning/methods , Receptors, Adrenergic, beta-2/metabolism , Signal Transduction , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Adenylyl Cyclases/metabolism , Adrenergic beta-2 Receptor Agonists/pharmacology , Animals , Cyclic AMP-Dependent Protein Kinases/metabolism , Dose-Response Relationship, Drug , GTP-Binding Protein alpha Subunits, Gs/metabolism , Gene Expression Regulation/drug effects , Intracellular Space/drug effects , Intracellular Space/metabolism , Ligands , Male , Mice , Mice, Inbred C57BL , Phosphatidylinositol 3-Kinases/metabolism , Reperfusion Injury/prevention & control , Signal Transduction/drug effects , rho-Associated Kinases/metabolism
2.
Eur Respir J ; 37(1): 173-82, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20595143

ABSTRACT

Bi-directional interactions between airway smooth muscle (ASM) and the altered extracellular matrix (ECM) may influence airway wall remodelling and ASM function in asthma. We have investigated the capacity of cultured human ASM to reorganise the structure of three-dimensional collagen gels and the effects of endothelin (ET)-1 and agents used to treat asthma. Human ASM cells were cast in type I collagen gels. Reductions in gel area over 72 h were determined in the absence and presence of ET-1 and potential inhibitors, steroids and ß2-adrenoceptor agonists. Changes in gel wet weights and hydroxyproline content were measured and ASM gel morphology was examined by scanning electron microscopy. Cell density-dependent reductions in gel area were augmented by ET-1, mediated via ET(A) receptors. This process was not associated with ASM contraction or proliferation, but was consistent with ASM tractional remodelling and migration leading to collagen condensation rather than collagen degradation within gels. The collagen remodelling by ASM was unaffected by salbutamol and/or budesonide. This study demonstrates an additional potential role for ASM in ECM regulation and dysregulation in airways disease that is resistant to steroids and ß2-adrenoceptor agonists. Therapy-resistant collagen condensation within ASM bundles may facilitate ECM-ASM interactions and contribute to increased internal airways resistance.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Collagen/chemistry , Muscle, Smooth/pathology , Steroids/pharmacology , Asthma/pathology , Bronchi/pathology , Calcium/chemistry , Cell Line , Cell Movement , Drug Resistance , Extracellular Matrix/metabolism , Glucocorticoids/metabolism , Humans , Hydroxyproline/chemistry , Matrix Metalloproteinase 2/metabolism , Microscopy, Electron, Scanning/methods , Models, Biological
3.
J Mol Biol ; 300(3): 481-91, 2000 Jul 14.
Article in English | MEDLINE | ID: mdl-10884345

ABSTRACT

A potential region of drug-DNA interaction in the A subunit of DNA gyrase has previously been identified from crystallographic studies. The local amino acid sequence has been compared with similar regions in yeast topoisomerase II and human topoisomerase IIalpha. Three non- conserved, potentially solvent-accessible residues at positions 762, 763 and 766 in human topoisomerase IIalpha lie between well-conserved regions. The corresponding residues in GyrA (83, 84 and 87) have a high frequency of mutation in quinolone-resistant bacteria. Mutations in human topoisomerase IIalpha have been generated in an attempt to engineer ciprofloxacin sensitivity into this enzyme: M762S, S763A and M766D (each mutated to the identical amino acid present in gyrase), along with an M762S/S763A double mutant and a triple mutant. These enzymes were introduced into a temperature-sensitive yeast strain, deficient in topoisomerase II, for in vivo studies, and were overproduced for in vitro studies. The M766D mutation renders the enzyme incapable of supporting the temperature-sensitive strain at a non-permissive temperature. However, both M766D and the triple mutant enzymes can be overproduced and are fully active in vitro. The double mutant was impaired in its ability to cleave DNA and had reduced catalytic activity. The triple mutation confers a three-fold increase in sensitivity to ciprofloxacin in vitro and similar sensitivities to a range of other quinolones. The activity of the quinolone CP-115,953, a bacterial and eukaryotic topoisomerase II poison, was unaffected by any of these mutations. Mutations in this region were found to increase the sensitivity of the enzyme to the DNA intercalating anti-tumour agents m-AMSA and ellipticine, but confer resistance to the non-intercalating agents etoposide, teniposide and merbarone, an effect that was maximal in the triple mutant. We have therefore shown the importance of this region in determining the sensitivity of topoisomerase II to drugs and have engineered increased sensitivity to quinolones.


Subject(s)
Anti-Infective Agents/pharmacology , DNA Topoisomerases, Type II/genetics , Mutation/genetics , Protein Engineering , Topoisomerase II Inhibitors , Amino Acid Sequence , Amino Acid Substitution/genetics , Antineoplastic Agents/pharmacology , Catalysis/drug effects , Ciprofloxacin/pharmacology , DNA Topoisomerases, Type II/chemistry , DNA Topoisomerases, Type II/metabolism , DNA, Superhelical/chemistry , DNA, Superhelical/genetics , DNA, Superhelical/metabolism , Genetic Complementation Test , Humans , Intercalating Agents/pharmacology , Microbial Sensitivity Tests , Models, Molecular , Molecular Sequence Data , Nucleic Acid Conformation/drug effects , Plasmids/chemistry , Plasmids/genetics , Plasmids/metabolism , Protein Conformation , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Temperature
4.
J Am Diet Assoc ; 91(6): 679-85, 1991 Jun.
Article in English | MEDLINE | ID: mdl-2040782

ABSTRACT

Serum lipid profiles, serum immunoglobulins, and serum proteins were investigated in 65 noninstitutionalized older women living in a rural community. All women were mentally and physically able to participate in the study. They did not have any overt disease nor were they taking any prescription or nonprescription drugs that would interfere with the study. Personal interview elicited medical history, drug usage, dietary information, height, and weight from 25 reference women (50 through 64 years old), 28 young-old women (65 through 84 years old), and 12 old-old women (85 through 92 years old). Blood samples were obtained from fasting participants and analyzed for total serum cholesterol, high-density-lipoprotein cholesterol, serum triglyceride, serum immunoglobulins (IgG, IgA, and IgM), serum albumin, and total serum protein. Serum lipids were not significantly affected by age, drug use, or age-by-drug use interaction. Effects of age were observed for IgA and serum albumin. Mean concentrations of serum immunoglobulins, serum albumin, and total serum proteins were within normal limits for all participants. Based on this small sample of rural older women, our results indicate that the normal levels of high-density-lipoprotein cholesterol and the healthy life-styles of these women may help offset any possible negative effects of elevated serum cholesterol concentrations.


Subject(s)
Blood Proteins/analysis , Diet , Immunoglobulins/analysis , Lipids/blood , Pharmaceutical Preparations/administration & dosage , Age Factors , Aged , Aged, 80 and over , Analysis of Variance , Body Height , Body Weight , Cholesterol/blood , Cholesterol, Dietary/administration & dosage , Dietary Fats/administration & dosage , Energy Intake , Fatty Acids/administration & dosage , Female , Humans , Iowa , Linoleic Acid , Linoleic Acids/administration & dosage , Middle Aged , Rural Population , Triglycerides/blood , Vitamin E/administration & dosage , Vitamin E/blood , Zinc/administration & dosage
5.
Vet Rec ; 113(13): 294-8, 1983 Sep 24.
Article in English | MEDLINE | ID: mdl-6688900

ABSTRACT

COSREEL, a computerised animal health recording system, has been used since October 1980 by two agricultural colleges for the management of their dairy herds. Each college and the veterinary practice which served the college has had its own typewriter terminal connected to a remote computer. Management and milk data have been coded and entered at the college and clinical data at the veterinary practice. An average of just over one management and veterinary event per week has been coded for every three cows in milk. Error rates were on average 11 per cent by one pair of users and 4 per cent by the other pair. COSREEL has provided a valuable aid to the management of the health of the two herds, and the regular use of pregnancy diagnosis, infertility investigation and oestrus detection action lists resulted in a considerable improvement in herd fertility at the two colleges.


Subject(s)
Animal Husbandry/methods , Cattle/physiology , Computers , Dairying/methods , Records , Software , Animals , Estrus Detection/methods , Female , Fertility , Mastitis, Bovine/epidemiology , Telephone/economics , United Kingdom
SELECTION OF CITATIONS
SEARCH DETAIL